Vaxil Bio Stock Buy Hold or Sell Recommendation
| VXL Stock | CAD 0.01 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Vaxil Bio is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Vaxil Bio given historical horizon and risk tolerance towards Vaxil Bio. When Macroaxis issues a 'buy' or 'sell' recommendation for Vaxil Bio, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Vaxil Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Vaxil and provide practical buy, sell, or hold advice based on investors' constraints. Vaxil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Vaxil |
Execute Vaxil Bio Buy or Sell Advice
The Vaxil recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Vaxil Bio. Macroaxis does not own or have any residual interests in Vaxil Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Vaxil Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Vaxil Bio Trading Alerts and Improvement Suggestions
| Vaxil Bio generated a negative expected return over the last 90 days | |
| Vaxil Bio has some characteristics of a very speculative penny stock | |
| Vaxil Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (254 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vaxil Bio has accumulated about 307 K in cash with (561 K) of positive cash flow from operations. | |
| Latest headline from news.google.com: Vaxil Bio 14-Day RSI 41.18 - GuruFocus.com |
Vaxil Bio Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (670K) | 1.4M | 731K | (731K) | (572K) | (543.4K) | |
| Free Cash Flow | (596K) | (1.1M) | (1.1M) | (734K) | (561K) | (589.1K) | |
| Net Income | (1.2M) | (1.4M) | (986K) | (584K) | (254K) | (266.7K) | |
| End Period Cash Flow | 753K | 83K | 1.5M | 2.2M | 938K | 665.5K | |
| Other Non Cash Items | 9K | 11K | 38K | 10K | (320.0) | (304.0) | |
| Net Borrowings | (32K) | (68K) | (21K) | (9K) | (8.1K) | (7.7K) | |
| Depreciation | 56K | 100K | 57K | 25K | 2K | 0.0 | |
| Change To Netincome | 97K | 151K | 161K | 70K | 63K | 59.9K |
Vaxil Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Vaxil Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Vaxil Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Vaxil stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Vaxil Bio Volatility Alert
At this time Vaxil Bio exhibits very low volatility. Vaxil Bio is a penny stock. Although Vaxil Bio may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Vaxil Bio. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Vaxil instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Vaxil Bio Fundamentals Vs Peers
Comparing Vaxil Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Vaxil Bio's direct or indirect competition across all of the common fundamentals between Vaxil Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Vaxil Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Vaxil Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Vaxil Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Vaxil Bio to competition |
| Fundamentals | Vaxil Bio | Peer Average |
| Return On Equity | -0.2 | -0.31 |
| Return On Asset | -0.1 | -0.14 |
| Current Valuation | 449.79 K | 16.62 B |
| Shares Outstanding | 136.98 M | 571.82 M |
| Shares Owned By Insiders | 8.16 % | 10.09 % |
| Shares Owned By Institutions | 0.01 % | 39.21 % |
| Number Of Shares Shorted | 3.73 K | 4.71 M |
| Price To Earning | (1.40) X | 28.72 X |
| Price To Book | 2.39 X | 9.51 X |
| EBITDA | (252) | 3.9 B |
| Net Income | (254 K) | 570.98 M |
| Cash And Equivalents | 307 K | 2.7 B |
| Total Debt | 85 K | 5.32 B |
| Debt To Equity | 11.20 % | 48.70 % |
| Current Ratio | 1.07 X | 2.16 X |
| Book Value Per Share | 0.01 X | 1.93 K |
| Cash Flow From Operations | (561 K) | 971.22 M |
| Short Ratio | 1.77 X | 4.00 X |
| Beta | -3.67 | -0.15 |
| Market Capitalization | 1.37 M | 19.03 B |
| Total Asset | 976 K | 29.47 B |
| Retained Earnings | (19.36 M) | 9.33 B |
| Working Capital | 891 K | 1.48 B |
| Net Asset | 976 K |
Vaxil Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Vaxil . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Vaxil Bio Buy or Sell Advice
When is the right time to buy or sell Vaxil Bio? Buying financial instruments such as Vaxil Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Vaxil Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Rentals Thematic Idea Now
Rentals
Companies providing rental and leasing services to public and business. The Rentals theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rentals Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Vaxil Stock Analysis
When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.